Come up with a name for your new list and we'll add to it:
DefiniGEN raised a round of funding on December 12, 2013. Investors include
Cambridge Enterprise Seed Funds.
DefiniGEN is focused on serving the growing need in the pharmaceutical industry for more accurate predictions of efficacy and toxicity in drug candidates ahead of clinical trials.…